Cargando…

High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission

We investigated the clinical implications of bacteremia among hospitalized COVID-19 patients. Higher rates (52.1%) of multidrug resistant organisms (MDRO) were noted on hospital admission compared to nosocomial acquisition (25%). Methicillin resistant Staphylococcus aureus was the predominant pathog...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhargava, Ashish, Riederer, Kathleen, Sharma, Mamta, Fukushima, Elisa Akagi, Johnson, Leonard, Saravolatz, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372431/
https://www.ncbi.nlm.nih.gov/pubmed/34416313
http://dx.doi.org/10.1016/j.ajic.2021.08.010
_version_ 1783739791532097536
author Bhargava, Ashish
Riederer, Kathleen
Sharma, Mamta
Fukushima, Elisa Akagi
Johnson, Leonard
Saravolatz, Louis
author_facet Bhargava, Ashish
Riederer, Kathleen
Sharma, Mamta
Fukushima, Elisa Akagi
Johnson, Leonard
Saravolatz, Louis
author_sort Bhargava, Ashish
collection PubMed
description We investigated the clinical implications of bacteremia among hospitalized COVID-19 patients. Higher rates (52.1%) of multidrug resistant organisms (MDRO) were noted on hospital admission compared to nosocomial acquisition (25%). Methicillin resistant Staphylococcus aureus was the predominant pathogen. Bacteremia with MDRO should be considered in the differential diagnosis among at risk populations especially those admitted from nursing facilities.
format Online
Article
Text
id pubmed-8372431
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-83724312021-08-18 High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission Bhargava, Ashish Riederer, Kathleen Sharma, Mamta Fukushima, Elisa Akagi Johnson, Leonard Saravolatz, Louis Am J Infect Control Brief Report We investigated the clinical implications of bacteremia among hospitalized COVID-19 patients. Higher rates (52.1%) of multidrug resistant organisms (MDRO) were noted on hospital admission compared to nosocomial acquisition (25%). Methicillin resistant Staphylococcus aureus was the predominant pathogen. Bacteremia with MDRO should be considered in the differential diagnosis among at risk populations especially those admitted from nursing facilities. Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2021-11 2021-08-18 /pmc/articles/PMC8372431/ /pubmed/34416313 http://dx.doi.org/10.1016/j.ajic.2021.08.010 Text en © 2021 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Report
Bhargava, Ashish
Riederer, Kathleen
Sharma, Mamta
Fukushima, Elisa Akagi
Johnson, Leonard
Saravolatz, Louis
High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission
title High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission
title_full High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission
title_fullStr High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission
title_full_unstemmed High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission
title_short High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission
title_sort high rate of multidrug-resistant organisms (mdros) among covid-19 patients presenting with bacteremia upon hospital admission
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372431/
https://www.ncbi.nlm.nih.gov/pubmed/34416313
http://dx.doi.org/10.1016/j.ajic.2021.08.010
work_keys_str_mv AT bhargavaashish highrateofmultidrugresistantorganismsmdrosamongcovid19patientspresentingwithbacteremiauponhospitaladmission
AT riedererkathleen highrateofmultidrugresistantorganismsmdrosamongcovid19patientspresentingwithbacteremiauponhospitaladmission
AT sharmamamta highrateofmultidrugresistantorganismsmdrosamongcovid19patientspresentingwithbacteremiauponhospitaladmission
AT fukushimaelisaakagi highrateofmultidrugresistantorganismsmdrosamongcovid19patientspresentingwithbacteremiauponhospitaladmission
AT johnsonleonard highrateofmultidrugresistantorganismsmdrosamongcovid19patientspresentingwithbacteremiauponhospitaladmission
AT saravolatzlouis highrateofmultidrugresistantorganismsmdrosamongcovid19patientspresentingwithbacteremiauponhospitaladmission